IntelliPharmaCeutics International (TSXV:IPCI) Other Long Term Assets : C$0.00 Mil (As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Other Long Term Assets?

IntelliPharmaCeutics International's other long-term assets for the quarter that ended in Aug. 2023 was C$0.00 Mil.

IntelliPharmaCeutics International's quarterly other long-term assets increased from Feb. 2023 (C$0.00 Mil) to May. 2023 (C$0.00 Mil) and increased from May. 2023 (C$0.00 Mil) to Aug. 2023 (C$0.00 Mil).

IntelliPharmaCeutics International's annual other long-term assets declined from Nov. 2020 (C$0.00 Mil) to Nov. 2021 (C$-0.00 Mil) and declined from Nov. 2021 (C$-0.00 Mil) to Nov. 2022 (C$-0.00 Mil).

IntelliPharmaCeutics International Other Long Term Assets Historical Data

The historical data trend for IntelliPharmaCeutics International's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Other Long Term Assets Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Other Long Term Assets

Get a 7-Day Free Trial

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

IntelliPharmaCeutics International Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines